Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学PI3K Inhibitor Alpelisib, HR+ Breast Europe

Martine Piccart

MD, PhD

🏢Jules Bordet Institute🌐Belgium

Professor of Oncology

87
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Martine Piccart is a towering figure in European breast oncology and has led or contributed to dozens of practice-changing clinical trials. She was the principal investigator of the SOLAR-1 trial establishing alpelisib plus fulvestrant as standard of care in PIK3CA-mutant HR+ metastatic breast cancer. She founded the BIG research group and has shaped global breast cancer clinical trial infrastructure.

Share:

🧪Research Fields 研究领域

alpelisib PI3K inhibitor
SOLAR-1 trial HR+
endocrine resistance Europe
breast cancer guidelines ESMO
HER2 combination therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Martine Piccart 的研究动态

Follow Martine Piccart's research updates

留下邮箱,当我们发布与 Martine Piccart(Jules Bordet Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment